| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 09/21/2011 | CN101306186B Traditional Chinese medicine taken orally for treating Qi stagnation and blood stasis type zoster |
| 09/21/2011 | CN101306096B Decoction for treating chronic eczema |
| 09/21/2011 | CN101229260B Chinese traditional medicine preparation for treating burns and scalds |
| 09/21/2011 | CN101204468B Wash-out medicine for infant eczema |
| 09/21/2011 | CN101204452B Tincture medicine for verruca plana |
| 09/21/2011 | CN101204426B Internal Chinese traditional medicine for summer dampness inducing soft furuncle |
| 09/21/2011 | CN101204410B External medicine for vitligo |
| 09/21/2011 | CN101199688B Tincture dose medicament for treating part frozen |
| 09/21/2011 | CN101199589B Tincture medicament for treating face vifiligo |
| 09/21/2011 | CN101199582B Paste medicament for treating acne |
| 09/21/2011 | CN101185705B Cream shape medicine for treating impetigo |
| 09/20/2011 | US8022105 Prevention of neutrophil recruitment |
| 09/20/2011 | US8022079 Methods of modulating PPAR gamma-type receptors |
| 09/20/2011 | US8022051 Composition for protection and improvement of skin, or reinforcing skin barrier function comprising phosphatidylserine |
| 09/20/2011 | US8022041 Prodrug of an ICE inhibitor |
| 09/20/2011 | US8021879 Adaptor protein that binds to mammalian toll-like receptor 3 and gene thereof |
| 09/20/2011 | US8021693 Methods of organ regeneration using Hox11-expressing pluripotent cells |
| 09/20/2011 | CA2516233C 2-propylidene-19-nor-vitamin d compounds |
| 09/20/2011 | CA2515484C Modulation of insulin like growth factor i receptor expression |
| 09/20/2011 | CA2484953C Microbial cellulose wound dressing for treating chronic wounds |
| 09/20/2011 | CA2476859C Water-based delivery systems |
| 09/20/2011 | CA2476619C Pet food composition for skin photoprotection |
| 09/20/2011 | CA2473686C Novel cytokine zcytor17 ligand |
| 09/20/2011 | CA2467774C Solubilized topoisomerase poisons |
| 09/20/2011 | CA2462903C Beta-lactamyl vasopressin v1a antagonists |
| 09/20/2011 | CA2461812C 3-(arylamino)methylene-1,3-dihydro-2h-indol-2-ones as kinase inhibitors |
| 09/20/2011 | CA2455328C New use of cyclolignans and new cyclolignans |
| 09/20/2011 | CA2411726C Use of ingenanes in treating a pkc-related condition or disorder |
| 09/20/2011 | CA2377977C Conjugates and methods for the production thereof, and their use for transporting molecules via biological membranes |
| 09/20/2011 | CA2376485C Recombinant anti-cd40 antibody and uses thereof |
| 09/20/2011 | CA2354475C Blends of isoflavones and flavones |
| 09/15/2011 | WO2011112421A2 Probiotic color cosmetic compositions and methods |
| 09/15/2011 | WO2011112414A2 Compound, composition, and method for protecting skin from high energy visible light |
| 09/15/2011 | WO2011111714A1 Novel ep4 agonist |
| 09/15/2011 | WO2011111707A1 Allergy inhibitor |
| 09/15/2011 | WO2011110918A1 Composition comprising probiotic bacteria for use in the treatment of immune disorders |
| 09/15/2011 | WO2011110225A1 Adhesive patch for therapeutic agent delivery |
| 09/15/2011 | WO2011065657A3 Compound comprising extracts or fractions of chrysanthemum boreale makino having anti-inflammation activity |
| 09/15/2011 | WO2011031554A3 Heterocyclic compounds as janus kinase inhibitors |
| 09/15/2011 | US20110224599 Combination of an oxidant and a photoactivator for the healing of wounds |
| 09/15/2011 | US20110224302 Difluorophenyldiacylhydrazide derivatives |
| 09/15/2011 | US20110224291 Skin external composition for inhibiting epidermal hyperproliferation and alleviating inflammatory skin diseases containing orthodihydroxyisoflavone derivatives |
| 09/15/2011 | US20110224268 Compositions and methods of using R(+) pramipexole |
| 09/15/2011 | US20110224267 Selective androgen receptor modulators |
| 09/15/2011 | US20110224262 Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto |
| 09/15/2011 | US20110224253 Small-molecule inhibitors of the androgen receptor |
| 09/15/2011 | US20110224251 Therapeutic Pyrazolyl Thienopyridines |
| 09/15/2011 | US20110224246 Pharmaceutical compositions comprising ascomycin |
| 09/15/2011 | US20110224243 FZD2 Molulators in the Treatment of Alopecia |
| 09/15/2011 | US20110224238 6, 9-Disubstituted Purine Derivatives and Their Use for Treating Skin |
| 09/15/2011 | US20110224237 Use of allopurinol for the treatment of palmar plantar erythrodysesthesia |
| 09/15/2011 | US20110224229 Novel Crystalline Form |
| 09/15/2011 | US20110224220 Substituted tricyclic derivatives |
| 09/15/2011 | US20110224217 Methods of treatment using heteroaryl compounds and compositions thereof |
| 09/15/2011 | US20110224216 Methods of Treating or Preventing Acute Erythema |
| 09/15/2011 | US20110224199 Heterocyclic Aromatic Compounds Useful As Growth Hormone Secretagogues |
| 09/15/2011 | US20110224192 3-Arylamino Pyridine Derivatives |
| 09/15/2011 | US20110224190 Piperidin-4-yl azetidine derivatives as jak1 inhibitors |
| 09/15/2011 | US20110224189 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases |
| 09/15/2011 | US20110224188 DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-alpha]IMIDAZOLE-3-CARBOXYLIC ACID AMIDES |
| 09/15/2011 | US20110224185 Compounds and compositions as modulators of gpr119 activity |
| 09/15/2011 | US20110224172 Substituted 1-Oxa-2,8-Diaza-Spiro [4,5] Dec-2-Ene Derivatives and Related Treatment Methods |
| 09/15/2011 | US20110224167 Skin-Protecting Alkalinity-Controlling Composition and the Use Thereof |
| 09/15/2011 | US20110224160 Use of Escin for Treatment of Type IV Hypersensitivity Reaction |
| 09/15/2011 | US20110224139 Protease-resistant mutants of stromal cell derived factor-1 in the repair of tissue damage |
| 09/15/2011 | US20110223621 Combinations for the treatment of immunoinflammatory disorders |
| 09/15/2011 | US20110223271 Phytocomplex from bergamot fruit, process of manufacture and use as dietary supplement and in the pharmaceutical field |
| 09/15/2011 | US20110223264 Substancefor Restoring Normal Co-expression and Interaction Between the LOX and NRAGE Proteins |
| 09/15/2011 | US20110223261 Stable cleanser compositions containing sulfur |
| 09/15/2011 | US20110223253 Physically stabilized biodegradable osteochondral implant and methods for its manufacture and implantation |
| 09/15/2011 | US20110223221 Stabilization processes of cation radicals of phenothiazinic compounds, cosmeceutical formulations and methods for skin diseases and disturbances prevention |
| 09/15/2011 | US20110223219 Probiotic Color Cosmetic Compositions And Methods |
| 09/15/2011 | US20110223193 Method for the preparation of medical devices and devices obtained therefrom |
| 09/15/2011 | US20110223178 Antibodies That Specifically Bind to Chemokine Beta-4 |
| 09/15/2011 | US20110223164 Binding domain-immunoglobulin fusion proteins |
| 09/15/2011 | US20110223141 Treatment of brain or spinal cord injury using placental stem cells |
| 09/15/2011 | US20110223139 Rapid preparation of stem cell matrices for use in tissue and organ treatment and repair |
| 09/15/2011 | US20110223130 USES OF IL-174 ANTAGONISTS FOR INHIBITING A Th2 IMMUNE RESPONSE |
| 09/15/2011 | US20110223127 SDF-1 Binding Nucleic Acids And The Use Thereof |
| 09/15/2011 | US20110223118 Antibacterial pharmaceutical composition comprising aceriphyllum rossii extract and active compounds isolated therefrom |
| 09/15/2011 | US20110223105 New 5-aminolevulinic acid prodrugs for use in photodynamic therapy and photodynamic diagnosis |
| 09/15/2011 | US20110220265 Preparation for External Use |
| 09/15/2011 | DE102010033301A1 Topically applicable medicament, useful for treating actinic keratosis, comprises diclofenac and chitosan |
| 09/15/2011 | CA2795977A1 Method of treatment |
| 09/15/2011 | CA2792811A1 Compound, composition, and method for protecting skin from high energy visible light |
| 09/15/2011 | CA2792403A1 Novel ep4 agonist |
| 09/15/2011 | CA2792343A1 Composition comprising probiotic bacteria for use in the treatment of immune disorders |
| 09/15/2011 | CA2791365A1 Probiotic color cosmetic compositions and methods |
| 09/14/2011 | EP2365006A2 Novel anti-IGF-IR antibodies and uses thereof |
| 09/14/2011 | EP2365005A2 Novel anti-IGF-IR antibodies and uses thereof |
| 09/14/2011 | EP2365004A2 Membrane associated tumor endothelium markers |
| 09/14/2011 | EP2364982A1 Spiro-piperidine compounds as chemokine receptor antagonists and medicinal use thereof |
| 09/14/2011 | EP2364731A2 Methods of administering anti-TNFalpha antibodies |
| 09/14/2011 | EP2364719A1 Prevention and treatment of amyloidogenic diseases |
| 09/14/2011 | EP2364692A2 Compositions including at least one derivative of naphtoic acid, benzoyl peroxide and at least one film-forming agent, methods for preparing same and uses thereof |
| 09/14/2011 | EP2364160A1 Compositions containing interleukin-1 and peptides |
| 09/14/2011 | EP2364136A1 Cosmetic use of skin cell autophagy activators |
| 09/14/2011 | EP2364135A2 Drug or dermatological composition containing an avocado peptide extract for treating and preventing pruritus |
| 09/14/2011 | EP2364088A1 Bicyclic aryl sphingosine 1-phosphate analogs |
| 09/14/2011 | EP1885741B1 Lys-thr dipeptides and their use |